Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medias Klinikum is a private specialized hospital located in Burghausen, Germany, that is internationally recognized for its expertise in surgical oncology and advanced regional chemotherapy (RCT). Led by Medical Director Prof. Dr. Karl R. Aigner, the clinic focuses on treating advanced-stage and therapy-resistant tumors that are often considered inoperable by conventional standards. Their core methodology involves isolated perfusion and intra-arterial infusion, which deliver high concentrations of chemotherapeutic agents directly to the tumor site while minimizing systemic side effects. This targeted approach allows for significantly higher drug efficacy compared to standard systemic chemotherapy. The clinic provides a comprehensive range of services, including specialized surgery, immunotherapy, and hyperthermia, tailored to individual patient profiles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medias Klinikum for Surgical Oncology.